FURLAN, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 6.518
AS - Asia 6.235
NA - Nord America 4.647
SA - Sud America 1.404
AF - Africa 131
Totale 18.935
Nazione #
US - Stati Uniti d'America 4.448
RU - Federazione Russa 4.361
SG - Singapore 2.385
CN - Cina 1.974
BR - Brasile 1.190
HK - Hong Kong 835
VN - Vietnam 523
IT - Italia 471
SE - Svezia 457
FR - Francia 354
DE - Germania 241
GB - Regno Unito 172
IN - India 132
CA - Canada 100
FI - Finlandia 92
AR - Argentina 83
NL - Olanda 77
MX - Messico 74
BD - Bangladesh 72
AT - Austria 66
PL - Polonia 61
ZA - Sudafrica 53
EC - Ecuador 43
ES - Italia 42
TR - Turchia 42
IE - Irlanda 40
JP - Giappone 37
IQ - Iraq 34
ID - Indonesia 31
UA - Ucraina 22
VE - Venezuela 22
SA - Arabia Saudita 20
UZ - Uzbekistan 19
MA - Marocco 17
PK - Pakistan 17
PY - Paraguay 17
CO - Colombia 15
LT - Lituania 14
TN - Tunisia 14
UY - Uruguay 14
IR - Iran 12
KE - Kenya 11
EG - Egitto 10
AZ - Azerbaigian 9
KR - Corea 9
OM - Oman 9
SN - Senegal 9
LB - Libano 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
CL - Cile 7
DZ - Algeria 7
NP - Nepal 7
RO - Romania 7
BE - Belgio 6
BO - Bolivia 6
JO - Giordania 6
IL - Israele 5
PE - Perù 5
BY - Bielorussia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KZ - Kazakistan 4
NI - Nicaragua 4
BH - Bahrain 3
CY - Cipro 3
KG - Kirghizistan 3
MD - Moldavia 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
KW - Kuwait 2
LY - Libia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 18.928
Città #
Singapore 1.086
Moscow 922
Dallas 884
Hong Kong 822
Ashburn 739
San Jose 645
Shanghai 356
Hefei 313
Lauterbourg 291
Beijing 222
Ho Chi Minh City 186
Lawrence 174
Princeton 172
Los Angeles 157
New York 156
São Paulo 137
Milan 134
Hanoi 109
Nuremberg 75
Santa Clara 66
Orem 62
Boardman 58
Munich 56
Warsaw 55
Washington 54
Helsinki 53
Chennai 51
Brooklyn 43
Montreal 40
London 38
Manchester 38
Atlanta 37
Denver 37
Dublin 37
Stockholm 34
Amsterdam 33
Rio de Janeiro 33
Rome 31
Da Nang 30
Houston 30
Poplar 30
Chicago 29
Guangzhou 29
Tokyo 29
Turku 29
Council Bluffs 28
Johannesburg 28
Seattle 26
Belo Horizonte 25
Haiphong 24
Vienna 23
Mexico City 22
Frankfurt am Main 21
Toronto 20
Naples 19
The Dalles 19
Phoenix 18
San Francisco 18
Querétaro 17
Boston 16
Cesano Boscone 16
Tashkent 16
Curitiba 15
Dhaka 15
Hangzhou 15
Porto Alegre 15
Quito 15
Shenzhen 15
Ankara 14
Brasília 14
Falkenstein 14
Campinas 13
Charlotte 13
Salvador 13
Guarulhos 12
Montevideo 12
Mumbai 12
Baghdad 11
Jeddah 11
Fortaleza 10
Kunming 10
Osasco 10
Pune 10
Ribeirão Preto 10
Xi'an 10
Baku 9
Betim 9
Caxias do Sul 9
Dakar 9
Florence 9
Guayaquil 9
Hải Dương 9
Lappeenranta 9
Nairobi 9
New Delhi 9
Tianjin 9
Assago 8
Biên Hòa 8
City of London 8
Columbus 8
Totale 9.418
Nome #
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 185
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 164
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 158
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 157
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up 131
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 129
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 122
One-year mental health outcomes in a cohort of COVID-19 survivors 118
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 115
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers 110
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 110
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 109
A model of HTLV-I infection in the SCID mouse 108
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 108
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 107
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study 107
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 105
INCREASE OF MYELOID MICROVESICLES IN THE CEREBROSPINAL FLUID AS BIOMARKER OF MICROGLIA/MACROPHAGE ACTIVATION IN NEUROLOGICAL DISORDERS 104
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis 104
Neuroinflammation in Bipolar Depression 104
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients 103
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 103
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 101
Classical and unconventional pathways of vesicular release in microglia 100
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 100
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 99
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 97
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates 96
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 96
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma 95
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 94
Inflammatory Markers Predict Blood Neurofilament Light Chain Levels in Acute COVID-19 Patients 94
Gene and stem cell therapy for autoimmune demyelination 92
miR-21 sustains CD28 signalling and low-affinity T-cell responses at the expense of self-tolerance 90
The microrna let-7b-5p is negatively associated with inflammation and disease severity in multiple sclerosis 90
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 89
iAstrocytes do not restrain T cell proliferation in vitro 88
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs 88
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 88
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS 87
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis 87
Acid sphingomyelinase activity triggers microparticle release from glial cells 87
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 87
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis 87
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 86
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 86
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 86
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 86
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 86
Absence of immunoglobulin restriction in tears from multiple sclerosis patients 85
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 85
A single nucleotide ADA genetic variant is associated to central inflammation and clinical presentation in MS: Implications for cladribine treatment 84
Dysregulation of MS risk genes and pathways at distinct stages of disease 83
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury 82
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 81
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking 81
Administration of an MCP-1 variant to EAE mice prevents inflammatory cell recruitment and protects from demyelination and axonal loss 80
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup 80
In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells 80
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 80
The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial 80
Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice 79
The impact of storage on extracellular vesicles: A systematic study 79
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 79
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects 78
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis 78
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease 78
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 78
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 77
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss 76
ACID SPHINGOMYELINASE TRIGGERS P2X7-INDUCED MICROPARTICLE RELEASE FROM GLIAL CELLS 74
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 73
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis 73
Acid sphingomyelinase activity triggers microparticle release from glial cells (vol 28, pg 1043, 2009) 73
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 72
Extracellular vesicles from adipose mesenchymal stem cells target inflamed lymph nodes in experimental autoimmune encephalomyelitis 72
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab 72
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis 72
Circulating cytotoxic immune cell composition, activation status and toxins expression associate with white matter microstructure in bipolar disorder 72
Extracellular Vesicles in Neuroinflammation 71
PD-1/PD-L Axis in Neuroinflammation: New Insights 70
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 70
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 69
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 69
A Tolerizing mRNA Vaccine against Autoimmunity? 68
Evaluation of different techniques to detect anti-acquaporin 4 antibodies in neuromyelitis optica patients 68
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 68
PD-L2 identifies a novel subpopulation of neutrophils displaying immunoregulatory features in Multiple Sclerosis 67
Distinct protein expression networks are activated in microglia cells after stimulation with ifn and il-4 67
T regulatory cells are markers of disease activity in multiple sclerosis patients 67
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression 67
A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking 66
Changes in circulating pro-inflammatory lymphocytes and cortical excitability with extended-interval natalizumab dosing in multiple sclerosis 66
Association between inflammation and brain microstructure in First Episode Psychosis investigated with DTI 66
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 66
Selective loss of microvesicles is a major issue of the differential centrifugation isolation protocols 63
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) 63
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs 63
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 63
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 62
Totale 8.858
Categoria #
all - tutte 106.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 2 0
2021/2022162 6 4 1 57 14 18 16 5 7 15 7 12
2022/20231.070 398 175 50 6 8 85 37 49 28 24 201 9
2023/2024784 7 44 108 61 103 174 20 62 8 26 34 137
2024/20253.776 376 68 54 94 130 313 499 323 662 576 324 357
2025/202613.525 1.036 1.052 1.091 1.911 1.048 399 1.486 1.110 3.876 516 0 0
Totale 19.401